The Stone Wars: Why ESWL Isn’t Going Away

Ureteroscopy won the volume race, but ESWL never left. ClearSight analyzed activity at 2,433 ESWL facilities to see how kidney stone treatment really divided.

Ureteroscopy won the volume race, but ESWL never left. ClearSight analyzed activity at 2,433 ESWL facilities to see how kidney stone treatment really divided.